Background: The number of adults with heart failure
Introduction
Patients living with the Patients living with the human immunodeficiency virus (HIV) who also have heart failure (HF) experience considerable disease considerable disease burden and distressing symptoms, have significant advanced care planning needs, and as a result may benefit from palliative care (PC). For example, patients living with HIV (PLWH) are younger at the time of HF diagnosis, experience faster progression to advanced HF, and have increased mortality risk compared to patients having HF without HIV. [1] [2] [3] They are more likely to be hospitalized and readmitted within 30 days for HF than their HIV-negative counterparts and are at increased risk of death, including sudden cardiac death, compared to HIV-negative patients with HF. 2, [4] [5] [6] [7] The PC needs of this population are likely to increase as the proportion of people with HF and concurrent HIV grows and increases in age and clinical complexity.
Palliative care improves symptoms, reduces hospital readmissions, facilitates end-of-life care planning, and enhances quality of life in patients with HF. 8 Among PLWH, prior to modern antiretroviral therapy (ART) when AIDS-defining illnesses were the primary cause of mortality, PC was routinely integrated into HIV care. 9, 10 However, the relationship between HIV infection and PC use among contemporary, comorbid patients with HF is not known. Therefore, we sought to examine whether HIV infection, and various characterizations of HIV infection, were associated with PC among a sample of patients hospitalized with HF as well as to identify other factors associated with PC use in this population.
Methods
Using a nested case-control study design, we sampled patients from the Veterans Aging Cohort Study (VACS) within the Veterans Health Administration (VHA). Veterans Aging Cohort Study is a longitudinal, observational study of all PLWH veterans in VHA care, matched 1:2 to HIV-negative comparators by age, race, gender, and VHA site-of-care. 11, 12 Participating institutional review boards approved VACS.
Selection of Case and Control Patients
The source population was 7496 patients hospitalized in a VHA facility with HF (International Classification of Diseases Ninth Revision [ICD-9] codes 425 or 428) 13 as a diagnosis during the study period defined as fiscal years 2003 to 2015, whose admission date was >1 year after cohort entry (to allow the recording of adequate clinical and health history data). We excluded participants with hospital lengths of stay <1 day because these patients likely died on the day of hospital admission or were transferred to another care setting. From this cohort, we identified as cases 211 patients using the first hospitalization for which records included the ICD-9 code V66.7. The VHA has required use of this code for tracking PC workload since 2002.
14 The code V66.7 is applied to hospitalization claims forms when palliative services are provided, including those provided by a PC consulting team, referral to or care at inpatient PC or hospice units, or treatments and services provided at the end of life. 15 The PC ICD-9 code was previously validated and has a sensitivity of 84% and specificity of 95% in VACS. 16 We matched the 211 cases to controls without a V66.7 code in a 1:5 ratio when possible, by age (+ 2 years), date of hospital discharge (+ 2 years), and left ventricular ejection fraction (LVEF; 40% vs < 40%). Left ventricular ejection fraction measurements were obtained from echocardiogram reports completed during hospitalization or within 6 months prior to hospitalization. The lowest LVEF during this timeframe was selected for matching.
Clinical Characteristics
We obtained clinical data from the electronic health record (EHR). We categorized HF (ICD-9 codes 425 or 428) either as the primary reason for the hospitalization using the principal diagnosis code or as a secondary diagnosis for the hospitalization. A principal diagnosis code reflects the primary condition associated with the hospitalization. We characterized HIV infection in 4 ways. We identified patients with HIV infection using ICD-9 codes, 11 those patients in which HIV infection was the primary hospital diagnosis for the hospitalization using the principal diagnosis code, patients with HIV who had unsuppressed HIV-1 RNA, defined as HIV-1 RNA of 500 copies/mL, 17 and patients with CD4 counts of <200 cells/mm 3 . A primary hospital diagnosis of HIV infection, unsuppressed HIV-1 RNA, and CD4 counts of <200 cells/mm 3 are suggestive of increased HIV-related disease severity. A primary hospital diagnosis of HIV is likely indicative of a more complex disease course. Unsuppressed HIV-1 RNA 500 copies/mL and CD4 counts of <200 cells/mm 3 are associated with significant morbidity and mortality risk. 18, 19 We defined smoking status as a history of never, past, or current tobacco use using health factors from the EHR. We identified hepatitis C infection by a combination of ICD-9 codes, positive antibody tests, or detectable plasma hepatitis C virus-RNA. 10 Comorbid conditions were defined by at least 1 inpatient or 2 outpatient ICD-9 codes for the conditions 1 year prior to and up to 30 days prior to hospitalization. This method of identification has been validated against medical record review and improves accuracy compared to a single code. 11 We selected comorbidities occurring frequently in VACS and those associated with HF for analysis a priori including alcohol use disorder, anemia, chronic renal failure, chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), major depression, diabetes mellitus (DM), and hypertension (HTN). We identified DM by ICD-9 code or by evidence of serum glucose meeting diagnostic criteria for DM.
11,12

Hospitalization Characteristics and Utilization
Hospitalization characteristics included length of hospital stay, admission to the intensive care unit (ICU; VHA bed section codes [12 or 13] ), and mechanical ventilation use during hospitalization (ICD-9 procedure code 96.7). Hospital utilization variables included the number of hospitalizations in the year prior to the index admission, the number of hospitalizations in the past year with a primary hospital diagnosis of HF, or with an ICU admission. Intensive care unit admissions included stays in the medical ICU or cardiac ICU, as separate bed section codes for cardiac ICU were not available until 2008. 20 
Statistical Analysis
We performed statistical analyses using SAS 9.4 (SAS Institute, Cary, North Carolina). We compared demographic, clinical, hospitalization, and utilization features of cases and controls using paired t tests and McNemar test for paired correlated proportions. We first explored associations between risk factors and PC in bivariate analysis selecting covariates with a P value <.10 for inclusion in multivariable models. We examined variables for confounding as well as collinearity. If variables were collinear, one was selected for inclusion based on face validity. Using these variables, we then constructed 4 multivariable models to evaluate associations between HIV infection identified by ICD-9 code (model 1), a primary hospital diagnosis of HIV (model 3), and unsuppressed HIV-1 RNA (model 4) and PC case status controlling for covariates using conditional logistic regression for matched sets. We created an adjusted final parsimonious model for HIV infection (model 2) identified by ICD-9 code leaving in those variables with statistically significant associations with PC (P < .05).
Results
Of the 210 matched cases, 206 patients had 5 matches, 2 patients had 4 matches, 1 patient had 3 matches, and 1 patient had 1 match.
Fewer matches were the result of age extremes and variations in discharge date. The final sample included 1252 patients (210 cases and 1042 controls). The majority (99%) of the sample was male, with a mean age of 64 (standard deviation + 10) years (Table 1) . Fifty-four percent of cases and 59% of controls were black, followed by white (33% for cases and controls), and other races (13% of cases and 8% of controls). Thirty-one percent of cases and 29% of controls had a primary hospital diagnosis of HF for the hospitalization (P ¼ .64). Thirty percent of cases and 31% of controls were PLWH (P ¼ .89). Multimorbidity was common among cases and controls, with similar proportions of HTN (cases ¼ 95%; controls ¼ 96%), CAD (cases ¼ 71%; controls ¼ 75%), anemia (cases ¼ 58%; controls ¼ 57%), chronic renal failure (cases ¼ 58%; controls ¼ 53%), and COPD (cases ¼ 55%; controls ¼56%) among groups (P > .05 for all). 
Discussion
In a sample of patients hospitalized with HF with and without HIV infection, we found that HIV infection by ICD-9 code in unadjusted and adjusted analysis was not associated with PC. Specific characteristics of HIV infection were, however, associated with PC provision. Patients admitted with a primary hospital diagnosis of HIV were 3.7 times more likely to receive PC during hospitalization than HIV-negative patients with HF. Those patients with unsuppressed HIV-1 RNA, that is HIV-1 RNA of 500 copies/mL, and patients with CD4 counts <200 cells/mm 3 were 2.7 times and 3.47 times more likely to receive PC during hospitalization, respectively.
To date, few studies have evaluated use of palliative and end-of-life care among contemporary PLWH populations. Among contemporary PLWH populations. Available evidence suggests that current utilization of PC for PLWH remains low. For example, Rhodes and colleagues found that only 6% of PLWH admitted to a single urban safety net hospital received PC prior to death. 21 A primary hospital diagnosis of HIV, unsuppressed HIV-1 RNA, and CD4 counts <200 cells/mm 3 likely indicate elevated HIV disease burden, and an increased risk for HIV-related complications including opportunistic infections and mortality. While Rhodes et al. 21 did not find an association between unsuppressed HIV-1 RNA and the use of hospice, our study provides new data which suggest that in patients admitted with HF with concomitant HIV, those patients with characteristics indicative of increased disease severity are more likely to receive PC during hospitalization. Use of PC for PLWH can lead to reduced symptoms, increased transfers to hospice, and completion of advanced directives. [22] [23] [24] However, our findings and those of others 21 suggest that among PLWH only a few and the very ill receive these benefits. There are likely several reasons for this finding. Clinicians may have difficulty recognizing the PC needs of patients with HF and comorbid HIV, such as pain and depression, symptoms that are present at diagnosis, and persist even with the use of ART therapies. 19, 25 Clinicians may also find prognostication and selecting a time to introduce PC challenging in patients with HIV and HF.
Patients with HIV and HF typically experiencing faster disease progression to advanced HF and increased mortality risk compared to HIV-negative patients with HF. [1] [2] [3] While this study found that use of PC was associated with advanced or uncontrolled HIV infection, this suggests that PC may be primarily provided late in the disease trajectory. Despite matching, patients in this study who received PC had longer hospital stays, were more frequently admitted to the ICU, and more often received mechanical ventilation, characteristics which support this hypothesis. Utilizing PC services earlier in the disease trajectory, rather than at times of critical illness, may offer greater benefits to these patients.
A diagnosis of depression was consistently associated with a reduced odds of PC during hospitalization in all of our analyses. Greener and colleagues found a similar but not statistically significant association between depression and use of PC in patients with HF. 26 Together, these findings may suggest that individuals with HF and depression face additional barriers to receiving PC during hospitalization. Several hypotheses could explain the negative relationship between depression and PC. Patients with comorbid depression may already receive care during hospitalization from inpatient psychiatric services that may deliver similar psychosocial interventions that could moderate the relationship between depression and PC. Alternatively, patients with depression may be less willing to engage with PC when offered such services, may be less likely to report psychosocial symptoms and other PC needs to healthcare providers, or may face bias from health-care providers leading to reduced likeliness of referral.
Our findings and those of others [26] [27] [28] [29] [30] [31] indicate that nondisease-specific characteristics such as hospital length of stay, use of invasive treatments such as mechanical ventilation, and frequent acute care encounters, could act as PC triggers to identify patients with advanced disease who may benefit from palliative intervention during hospitalization. Developing triggers for PC referral for patients with noncancer conditions such as HF and HIV is an area in need for ongoing research. It remains challenging to identify easily accessible patient triggers for PC referral within the EHR, in part due to difficulties in prognostication particularly for patients with serious, noncancer conditions. 27, 28 Although disease trajectories across cancer, organ failure, or physical and frailty may differ, 29 complicated or prolonged hospitalizations likely signal functional decline, which, regardless of underlying mechanisms, could benefit from palliative intervention.
A strength of this study is the use of a large nationwide sample of hospitalized patients with HF from the VHA. We identified PC using a validated ICD-9 code, increasing the reliability of our findings. 16 In addition, the VHA was an optimal setting for this study, as it was an early adopter of PC, developing PC workflow capture guidelines in 2002 and mandating the creation of PC consultation teams at all VHA institutions in 2003. 25, 30 This study also has several limitations. Our study sample was comprised of mostly male veterans with HF who were younger than other research cohorts of patients with HF receiving PC. 26, 31 This, in addition to the relatively small sample size, may limit the generalizability of study findings. Although we assessed associations between HIV and PC, we did not evaluate the relationship between specific AIDS-defining conditions such as Pneumocystis jirovecii pneumonia or Kaposi sarcoma and PC use. AIDS-defining conditions may factor less in PC referral, given the widespread use of ART, with PLWH with access to ART now more likely to die from comorbid conditions than HIV. 32 In addition, we did not assess for the relationship between symptoms and PC such as pain and fatigue, which are common in both HIV and HF populations and are associated with poor outcomes including reductions in quality of life and mortality. 33, 34 Finally, although patients were matched on several demographic and clinical variables, we could not control for unmeasured differences between the groups.
Our findings highlight several areas in need of ongoing research. Exploration into potential barriers to PC provision for patients with HIV is needed. Our findings and others 21, 35 also underscore the need for interventions aimed at increasing access to PC for patients with HIV and concomitant HF. Finally, given the prevalence of depression in HIV of approximately 40% to 42% 36 and 20% to 30% in HF, 37 replication of study findings and further exploration into the relationship between depression as well as other psychiatric illnesses and use of PC is warranted.
Conclusion
This study adds important empirical information to the understanding of factors associated with use of PC among patients with HIV and HF. In a sample of patients hospitalized with HF in the VHA we found that characteristics suggestive of HIV disease complexity and burden were associated with an increased likeliness of PC use. Increasing timely access to PC for patients with HF and concurrent HIV is warranted.
